Advances in target validation, screening technologies, and discovery of new ion channel families combine to enable the investigation and commercialization of this largely unexploited target family with potential in a range of major therapeutic areas.
Creator
Wilma Keighly
Date
2012/03/28
Type
Text
Format
application/pdf
Identifier
BI00040-007
Language
English
Rights
Licensed for Authorized Users at Simon Fraser University